Table 1.
Clinical and analytical characteristics of the study cohort employed for immunohistochemistry and gene expression analyses.
| Variable | Overall cohort (n = 17) |
|---|---|
| Age, years | 44.1 ± 13.1 |
| Sex distribution (male), % | 47.1% (8/17) |
| BMI (kg/m2) | 29.04 ± 5.02 |
| T2DM, % | 29.4% (5/17) |
| Arterial hypertension, % | 29.4% (5/17) |
| Dyslipidemia, % | 52.9% (9/17) |
| AST (IU/mL) | 41 ± 23 |
| ALT (IU/mL) | 55 ± 34 |
| GGT (IU/mL) | 95 ± 105 |
| Glucose (mg/dL) | 100 ± 41 |
| Insulin (microUI/mL) | 13 ± 9 |
| Triglycerides (mg/dL) | 119 ± 87 |
| Total cholesterol (mg/dL) | 190 ± 46 |
| Albumin (mg/dL) | 4252 ± 310 |
| Platelet count, ^109 | 207 ± 56 |
| Significant fibrosis (F2–F4), % | 41.2% (7/17) |
BMI body mass index, T2DM type 2 diabetes mellitus, AST aspartate aminotransferase, ALT alanine aminotransferase, GGT gamma glutamil transferase.